MSB 3.21% $1.13 mesoblast limited

Regulatory Pathways - where we stand with the FDA, page-14

  1. 4,194 Posts.
    lightbulb Created with Sketch. 5493
    Agreed.

    All evidence suggests we are going to get answers from the FDA this year on all indications, and confirmation of at least 1 huge partnership. If your in it for the risk / reward.... this would be the time to be holding prior to those meetings and partnership announcements.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.